Correlation Between Pfizer and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Pfizer and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Cue Biopharma, you can compare the effects of market volatilities on Pfizer and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Cue Biopharma.
Diversification Opportunities for Pfizer and Cue Biopharma
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pfizer and Cue is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Pfizer i.e., Pfizer and Cue Biopharma go up and down completely randomly.
Pair Corralation between Pfizer and Cue Biopharma
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Cue Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 4.53 times less risky than Cue Biopharma. The stock trades about -0.07 of its potential returns per unit of risk. The Cue Biopharma is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 357.00 in Cue Biopharma on August 25, 2024 and sell it today you would lose (255.00) from holding Cue Biopharma or give up 71.43% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. Cue Biopharma
Performance |
| Timeline |
| Pfizer Inc |
| Cue Biopharma |
Pfizer and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and Cue Biopharma
The main advantage of trading using opposite Pfizer and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| Pfizer vs. AbbVie Inc | Pfizer vs. Merck Company | Pfizer vs. Eli Lilly and | Pfizer vs. Bristol Myers Squibb |
| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |